AstraZeneca
AstraZeneca is a global biopharmaceutical company known for its innovative medicines, particularly in the fields of oncology, cardiovascular, renal, and respiratory diseases. Recently, the company announced a significant investment of $2.5 billion to establish a global strategic research and development center in Beijing.
Not in the pool (under ¢1).
Recent news mentions
AstraZeneca announced plans to invest over 100 billion yuan in China by 2030 to expand its pharmaceutical production.
国际锐评丨欧洲政要密集访华背后的时与势 _光明网
China· 2026-01-31
AstraZeneca announced plans to invest over 100 billion yuan in China by 2030.
習晤施紀賢 盼中英合作「大有作為」 英威士忌有望降關稅 阿斯利康擬在華投資千億 - 20260130 - 中國 - 每日明報
Hong Kong· 2026-01-29
AstraZeneca announced multimillion-dollar investments in the United States, committing to reduce their fees in exchange for tariff exemptions.
Reino Unido concluye acuerdo de ‘cero aranceles’ en productos farmacéuticos con Estados Unidos
Costa Rica· 2025-12-02
AstraZeneca announced an additional investment of $136 million to expand its production capacity in Qingdao.
进博会规模为何再创新高（现场评论） _光明网China· 2025-11-08
AstraZeneca insists on the legality of its existing patent and its rights to the drug.
Суды разрешили госзакупки препарата от диабета вопреки решению ФАС — РБК
Russia· 2025-04-10
AstraZeneca announced a $2.5 billion investment plan to establish a global strategic R&D center in Beijing.
投资中国就是投资未来 --观点--人民网China· 2025-04-01
AstraZeneca announced an investment of $2.5 billion to establish a global strategic R&D center in Beijing.
經濟 - 20250322 - 每日明報Hong Kong· 2025-03-22